@article{oai:repo.qst.go.jp:00047458,
 author = {Rumiana, Bakalova and Zhelov, Zhivko and Nikolova, Billiana and Murayama, Shuhei and Lazarova, Desislava and Tsoneva, Idana and Aoki, Ichio and Saga, Tsuneo and バカロバ ルミアナ and 村山 周平 and 青木 伊知男 and 佐賀 恒夫},
 issue = {4},
 journal = {General Physiology and Biophysics},
 month = {Oct},
 note = {The present study was designed to investigate whether poly-ion complex hollow vesicles (polymersomes), based on chemically-modified chitosan, are appropriate for lymph node mapping in the context of their application in the development of theranostic nanosized drug delivery systems (nano-DDS). The experiments were performed on Balb/c nude mice (colon cancer-grafted). The mice were subjected to anesthesia and quantum dot (QD705)-labeled polymersomes (d~120 nm) were injected intravenously via the tail vein. The optical imaging was carried out on Maestro EX Imaging System (excitation filter: 435–480 nm; emission filter: 700 nm). A strong fluorescent signal, correspondingto QD705 fluorescence, was detected in thelymph nodes, as well as in the tumor. A very weak fluorescent signal was found in the liver area. The half-life of QD705-labelled polymersomeswas 6 ± 2 hours in the bloodstream and 11 ± 3 hours in the lymph nodes. The data suggest that polymersomes are very promising carriers for lymph node mapping using QD as a contrast agent. They are useful matrix for development of nano-formulations with theranostic capabilities.},
 pages = {393--398},
 title = {Lymph node mapping using quantum dot-labeled polymersomes},
 volume = {34},
 year = {2015}
}